Background
The traditional fashion that patients preoperatively fast from midnight to minimum 6 h for solid food and 4 h for fluids before an elective surgery to prevent vomiting and aspiration pneumonia has been challenged by various studies [
1,
2]. Therefore, several updated guidelines encourage patients to take clear fluids up to 2 h before an elective operation with strong grade recommendations [
3‐
6].
Accumulated evidences have showed that shortening of the fasting interval will not decrease the pH, or increase the volume of gastric contents related to perioperative complications [
7,
8]. Moreover, it could alleviate both preoperative [
9] and postoperative [
10,
11] discomfort (e.g. nausea and vomiting). Prolonged interval of fasting (e.g. overnight fasting) is detrimental to patients’ postoperative recovery [
12]. This was mainly on account of the stress response-related postoperative insulin resistance. Lower insulin resistance was found when oral carbohydrate beverage was taken before operation, compared with fasting or placebo drinks in several trials [
13‐
15].
The European Society of Anaesthesiology recommended clear fluids, including pulp-free juice, tea, and coffee to drink up to 2 hours before an elective caesarean delivery (CD) [
5]. Moreover, guidelines for antenatal and preoperative care in caesarean delivery published by Enhanced Recovery After Surgery (ERAS) Society in 2018 made the same recommendation with strong grade. Nevertheless, the grade of the recommendation for oral carbohydrate fluid supplementation taken 2 hours before CD was weak due to the low-level evidence [
16]. Our study is aiming to address the impact of preoperative carbohydrate fluid supplementation on postoperative insulin resistance and discomfort in pregnant women undergoing elective CD, as well as on neonatal glucose level.
Methods
Study design
This was a randomized controlled trial involving oral administration of carbohydrate supplement before elective CD, compared with preoperative fasting and preoperative water intake, respectively, in order to determine the impact of preoperative carbohydrate supplement on pregnant women’s postoperative blood glucose level, insulin level, insulin resistance, perioperative discomfort, as well as neonates’ blood glucose level.
Participants
Women with a singleton pregnancy, who were planned to receive an elective CD at Shanghai Tenth People’s Hospital were recruited. The exclusion criteria were women with gestational diabetes mellitus according to the International Association of Diabetes and Pregnancy Study Groups (IADPSG) [
17], or gestational hypertension according to the American College of Obstetricians and Gynecologists (ACOG) diagnostic criteria [
18]. Women with overweight or obese pre-pregnancy BMI according to the Chinese standards (i.e. BMI ≥ 24), or having hepatic disease (including intrahepatic cholestasis during pregnancy) were also excluded. The purposes and details of the study were notified to the pregnant women. Meanwhile, written consents were obtained from them before recruitment. The trial was approved by the local ethics committee at Shanghai Tenth People’s Hospital and carried out in accordance with the Helsinki Declaration.
Intervention
All the participants were randomized with an allocation ratio of 1:1:1 by an independent research assistant who was not involved in the following process, via a random number generator tool in Microsoft Excel (Microsoft, Redmond, WA). Group allocations were placed in sequentially numbered opaque sealed envelopes. After obtaining consent forms, pregnant women were included in the trial. Both the surgeons and the researchers were blinded to the treatment assignment.
The first surgery started at 8:30 AM and subsequent surgeries followed. All the surgeries initialled before 12:00 PM. Pregnant women allocated to the Ch-R group received 400 ml oral carbohydrate-rich (Ch-R) solution (Shu Yu™, Chongqing, China, supplementary note
1) 2 hours before the CD. The Ch-R solution had the same appearance but different taste compared with clear water, and contained 12.5 g carbohydrate and 213 kJ caloric per 100 ml. Pregnant women allocated to the placebo group took a placebo (400 ml clear water) 2 hours before the CD. Pregnant women allocated to the fasting group abstained from solid food or fluids before the CD. The last solid meal was given to all women in the evening before the surgery. Oral fluids were stopped by 22:00 on the day before the surgery day. None of the women received pre- or intraoperative intravenous infusion of glucose solution. During the CD, 1000–1500 ml of crystalloids was intravenously infused. After surgery, 1500–2000 ml of crystalloids, including 500 ml 5% glucose solution was infused when returning to the ward. Women were allowed to take liquid diet 6 hours after the operation. The manner of the CD was transverse incision of the lower uterine segment under spinal anaesthesia.
Exposure variables
Maternal BMI at delivery was calculated as weight (kg) / height2 (m2), where weight and height were measured when patients were admitted for delivery. Gestational age (GA) was recorded on the day of operation. The duration of surgery was timed from disinfection until patients left the surgery room. Meanwhile, neonatal birth weight and sex were recorded.
Outcome variables
Pregnant women’s plasma glucose and insulin levels were examined to assess the impacts on glucometabolic. Blood samples were delivered to the laboratory immediately. The assays were conducted within 2 hours by using hexokinase and electrochemiluminescence methods, respectively. The primary outcome was pregnant women’s postoperative insulin resistance evaluated by the homeostatic model assessment of insulin resistance (HOMA-IR) index, which was calculated according to the formula: HOMA-IR = blood glucose level (mmol/L) x blood insulin level (mIU/L) / 22.5. Blood samples before intervention were taken from every woman at 2 hours before the CD (before preoperative carbohydrate-rich solution or water was taken), while blood samples immediately after and 1-day after the CD were obtained when they returned to the ward from the surgery room immediately, and 6:00 AM on the day after the surgery day, respectively.
Pregnant women’s perioperative symptoms and signs were also accessed as secondary outcomes. The questions were asked and recorded by an independent research assistant. Women were asked to rate their thirst and hunger on a 10-cm visual analogue scale, with 0 representing “not thirsty/hungry at all” and 10 representing “extremely thirsty/hungry” on arrival at the surgery room. Questions about the occurrences of intra- or postoperative nausea and vomiting were asked 24 h after the CD. Time of flatus started when women arrived at the ward after the CD. Oral temperatures were measured four times 1 day in the first 48 h after the CD, and postoperative fever was diagnosed once temperature was equal to or higher than 37.5 °C. Women were discharged on the fourth day after the CD, unless complication existed.
For neonatal outcomes, 1-min Apgar score and blood glucose level were recorded. Capillary blood glucose level was measured on heel within 20 min after delivery.
Sample size
The sample size was calculated based on the HOMA-IR outcomes of a pilot study. Ten pregnant women in total were stratified into Ch-R group and fasting group equally. As a result, 17 patients in the fasting group would achieve a 91% power to detect a difference of − 0.6 to the CHR group with a significance level (alpha) of 0.05 using a two-sided t-test. Accounting for 20% loss to complete the protocol, at least 23 patients per group were required in the study.
Statistical methods
Continuous variables were expressed as median (Q1-Q3) since the data of each group were not normally distributed with a small sample size. The Kruskal-Wallis test was carried out, followed by post-hoc pairwise comparison with Bonferroni correction if the null hypothesis was rejected. Dichotomous variables were expressed as number (percentage), and analysed via the χ2 test or Fisher’s Exact test when appropriate.
Furthermore, several traits were adjusted for covariates using linear regression as follows: maternal postoperative biochemical indices were adjusted for relevant preoperative variables, age, BMI and duration of the operation, while neonatal blood glucose level was adjusted for sex and birth weight. Two dummy variables were used to code for the categories, “Ch-R group” and “placebo group”. Each group was compared with the reference category “fasting group”. Meanwhile, repeated measures ANOVA were performed to test the differences over time, as well as the interaction between groups and time.
SPSS version 22 software (SPSS, Chicago, IL) was used to perform all statistical analysis. GraphPad Prism 5.0 software (GraphPad Software, Inc., La Jolla, CA, USA) was employed to plot the graphs. P < 0.05 was considered to indicate a statistically significant difference.
Discussion
With evidence accumulated, fasting guidelines in various countries were updated to permit clear liquid up to 2–3 h before surgery. Randomized controlled trials and meta-analysis have demonstrated that preoperative fluid intake would improve the feeling of well-being and alleviate thirst and dryness of the mouth [
10,
12]. A specially designed high-carbohydrate contained beverage administrated in the preoperative period is recommended due to the reduction of the catabolic stress response to the surgery [
14]. The ERAS society encouraged oral carbohydrate fluid supplementation 2 hours before caesarean delivery to nondiabetic women in the guidelines for antenatal and preoperative care in caesarean delivery in 2018. Nevertheless, the grade of the recommendation was weak due to the low-level evidence [
16]. Our finding showed that the administration of oral carbohydrate-rich solution 2 hours before caesarean delivery may not only reduce the maternal postoperative insulin resistance, but also increase the neonatal glucose level.
Crenshaw et al. found that both actual and instructed fasting durations prior to the CD were longer than national guidelines in US. The average thirst and hunger scores were 5 and 4, respectively [
19]. Another previous study showed that the duration of fluid fasting in women undergoing elective CD was correlated with thirst scores and urine osmolality [
20]. Meanwhile, latest findings from Wendling et al. found that a higher-dose carbohydrate beverage consumed preoperatively resulted in superior well-being compared to fasting, which was consistent with our findings [
21]. However, considering patients were not blind in our study, bias may have occurred accordingly.
A recently published study found that carbohydrate drinks ahead of CD reduced the incidence of urinary ketones immediately prior to surgery [
22]. Our study used HOMA-IR index to access the metabolic state. The impact of preoperative carbohydrate supplement on the reduction of postoperative insulin resistance has been found in other types of surgeries [
2,
15]. Insulin resistance is one of the most fundamental reactions to injury and stress. Previous studies in elective surgeries suggested that insulin resistance was associated with prolonging recovery and postoperative complications, in particular infections [
23]. The main objective of the preoperative carbohydrate supplement is to mimic a change in metabolism that generally occurs due to breakfast intake. It will elicit an endogenous insulin release that turns off the overnight fasting state of the metabolism in order to improve postoperative recovery [
24].
A cross-sectional study involved approximate 3000 Chinese adults showed the 75th (1.4) and 90th (2.0) percentiles of HOMA-IR index were appropriate to be the optimal cut-off points to discriminate dysglycemia and Type II diabetes, respectively [
25]. The medians of HOMA-IR index before intervention in our study exceeded the 90th percentiles in all three groups, which implied a high risk of insulin resistance, and is detrimental to postoperative recovery. Nevertheless, only the median of HOMA-IR index in Ch-R group restored to the level less than 75th percentile immediately after the CD, which may reduce the risk. All participants’ HOMA-IR indices descended to normal level on the day after the surgery day. This may be partly influenced by the postoperative infusion of 500 ml 5% glucose solution after the surgery.
Li et al. found that shorter fasting interval (solid food < 8 h and clear fluid < 2 h) reduced the incidence of hypoglycaemia and acidosis in neonates. However, the incidence of vomiting of women increased while the fasting interval of solid food reduced to less than 6 hours [
26]. On the other hand, intravenous glucose solution administered during the CD has increased both the maternal and neonatal glucose level [
27]. We noticed that the mean umbilical cord blood glucose level of those who had drunk preoperative oral carbohydrate beverage in Wendling et al.’s study was relative higher (
p > 0.05) [
21]. Fortunately, with a larger sample size, a significant difference was obtained in our study. Our finding suggested that the oral carbohydrate-rich solution administered 2 hours prior to CD may independently increase the neonatal glucose level, apart from increasing the risks of maternal hyperglycaemia, vomiting or nausea.
There were several limitations in our study. The fasting-CD intervals, as well as the contents of last meals varied among individuals, and were not recorded and standardized in the study. On the other hand, with such a small sample size, we are incapable to address the impact of preoperative oral carbohydrate-rich solution on adverse anaesthetic outcomes.
Conclusions
Oral Ch-R solution administered 2 hours before an elective CD may not only alleviate maternal postoperative insulin resistance, but also comfort women’s preoperative thirst and hunger, compared to fasting. Additionally, it may increase neonatal glucose level as well. Our findings support the recommendation on carbohydrate-rich solution prior to elective CD.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit
http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (
http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.